Mirae Asset Healthcare Fund
Mirae Asset Mutual Fund · Sectoral / Thematic · Direct Growth · AMFI 143783 · ISIN INF769K01ED6
NAV₹55.777020 Nov 2026
3Y return+24.02%a year
5Y return+17.98%a year
Expense ratio0.59%₹3,562 Cr
Growth Score87.1★★★★★
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | +13.39% | +8.55% | +15.35% | +30.13% | +29.07% | +24.02% | +17.98% | +25.99% | — | +22.65% |
| NIFTY Healthcare TRI | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Category middle | +7.16% | +0.76% | +8.62% | +4.78% | +4.45% | +14.50% | +13.44% | +17.71% | +15.62% | — |
Risk (36 months)
| Volatility | 15.52% |
| Sharpe | 1.13 |
| Sortino | 2.00 |
| Beta | 0.96 |
| Alpha | +3.14% |
| Deepest fall | -19.98% |
| 1-year periods with a loss | 18% |
| 5Y SIP XIRR | +22.86% |
Top holdings (31 Oct 2026)
| Sun Pharmaceutical Industries Ltd. | 10.32% |
| Divi's Laboratories Ltd. | 9.97% |
| Torrent Pharmaceuticals Ltd. | 6.41% |
| Laurus Labs Ltd. | 6.37% |
| Apollo Hospitals Enterprise Ltd. | 5.81% |
| Dr. Reddy's Laboratories Ltd. | 5.45% |
| Glenmark Pharmaceuticals Ltd. | 4.61% |
| Aurobindo Pharma Ltd. | 3.73% |
| Alkem Laboratories Ltd. | 3.65% |
| Krishna Institute of Medical Sciences Ltd. | 3.48% |
| IPCA Laboratories Ltd. | 3.33% |
| Sai Life Sciences Ltd. | 3.23% |
Sectors
| Pharmaceuticals & Biotechnology | 75.9% |
| Healthcare Services | 20.5% |
| Chemicals & Petrochemicals | 1.8% |
| Healthcare Equipment & Supplies | 1.7% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.